Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
05/2008
05/15/2008WO2008008660B1 Cyclopentane derivatives as antiglaucoma agents
05/15/2008WO2001056933A3 Combined supported liquid membrane/strip dispersion processes and extractants
05/15/2008US20080114191 Minimization of ligand degradation products, or reversion of same to useful phosphine ligands
05/15/2008US20080114184 Novel Fluorine-Containing Polyether Phosphonic Acid Ester Compound and Process For Producing the Same
05/15/2008US20080114168 Novel esters as useful broad spectrum herbicidal compounds
05/15/2008US20080114165 Methods for the Preparation of {2-[(8,9)-Dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} Phosphonic Acid and Esters Thereof
05/15/2008US20080114061 Diphenylethylene compounds and uses thereof
05/15/2008US20080113972 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis
05/15/2008US20080113942 Phosphorylcholine Group-Containing Compound and Method for Producing Same
05/15/2008US20080113941 4-O esters of podophyllotoxin and 4'-demethylepipodophyllotoxin 4'-phosphonic acid or phosphonate derivatives; anticancer agents; type II DNA topoisomerase (topoisomerase II) inhibitors
05/15/2008US20080113200 has lower levels of fluorine, use as surfactants, additives for coatings providing water repellency, oil repellency and stain resistance; superior surface effects
05/15/2008US20080113102 a mixture of water soluble antimony, bismuth, tellurium and tin compounds or mixtures, including nickel and manganese salts, tannins and thioureas, used for impart corrosion resistance
05/15/2008US20080112917 Sphingolipids' Polyalkylamines Conjugates
05/15/2008US20080112866 Functionalized ionic liquids, and methods of use thereof
05/15/2008DE102004029697B4 2-Amino- und 2-Hydroxy-2-phosphinoalkansäure-Derivate und 2-Phosphoniobis(2-hydroxyalkansäure)-Derivate, Verfahren zur Herstellung dieser Derivate und Verwendung der Derivate zur Herstellung von 2-Amino- oder 2-Hydroxyphosphinoalkanoat-Nickel-Derivaten 2-amino and 2-hydroxy-2-phosphinoalkansäure derivatives and 2-Phosphoniobis (2-hydroxyalkanoic acid) derivatives, processes for preparing these derivatives and use of the derivatives for the preparation of 2-amino or 2-Hydroxyphosphinoalkanoat nickel derivatives
05/15/2008CA2669450A1 Novel nucleotide analogues as percursor molecules for antivirals
05/15/2008CA2668923A1 Use of tri-substituted glycerol compounds for the treatment of radiation injuries
05/15/2008CA2668783A1 Process for the preparation of biphosphonic acids and salts thereof
05/14/2008EP1921083A1 Phosphite composition and method for producing the same
05/14/2008EP1920824A1 Ionic liquids and uses thereof
05/14/2008EP1366004B1 Catalytic hydrogenation processes
05/14/2008CN101180303A Metal hydride complex, method of hydrogenating ring-opening polymerization polymer of cycloolefin, and process for producing product of hydrogenation of ring-opening polymerization polymer of cycloole
05/14/2008CN101180302A Process for preparing (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
05/14/2008CN101180297A Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
05/14/2008CN101180097A Novel phosphinic acid-containing thyromimetics
05/14/2008CN101177557A Small particle copper pyrithione
05/14/2008CN101177433A (s)-ornidazole disodium phosphate pentahydrate as well as preparation method and uses thereof
05/14/2008CN101177432A Steric isomer of chlormephos, preparation and use thereof and composition using the isomer as active component
05/14/2008CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease
05/14/2008CN100387606C Method for the production of cyclic phosphonic acid anhydrides
05/13/2008US7371887 Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly
05/13/2008US7371878 vapor tantalum complex recursor for vapor depositing a barrier layer selected from tantalum nitride, tantalum oxide or bismuth tantalum oxide; chemical vapor deposition and atomic layer deposition; integrated circuits has copper or ferroelectric thin films
05/13/2008US7371877 Glycerol ester derivative
05/13/2008US7371871 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents, sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents, drug abuse withdrawl
05/13/2008US7371857 Synthesis for hydroxyalkylated heterocyclic bases
05/13/2008US7371740 Phosphorylated glyceryl ether aluminum salt
05/13/2008US7371739 Aryl fructose-1,6-bisphosphatase inhibitors
05/13/2008US7371705 obtained by combining a Group VIII metal or a compound thereof and a bidentate phosphine; carbonylation of ethylenically unsaturated compounds with CO in the presence of a source of hydroxyl groups (water or an alcohol)
05/13/2008CA2434790C Method for isolating pharmaceutically exploitable etidronate disodium
05/13/2008CA2384027C Fungicides
05/13/2008CA2234284C Solid biologically active silicon-based compounds
05/13/2008CA2214894C Substituted dibenz[a,f]azulenes and methods of preparation
05/08/2008WO2008054625A2 Anti-friction and anti-wear lubricant additives
05/08/2008WO2008054550A1 Radiation absorbing compositions, methods and articles incorporating such compositions
05/08/2008WO2008053803A1 Phosphorus-molybdenum compound, method for producing the same, lubricant additive containing the compound, and lubricant composition
05/08/2008WO2008052631A1 [(4-oxo-4h-chromen-3-yl)-hydroxy methyl]- or [(4-oxo-4h-chromen-3-yl)-methyl]-phosphonic acid derivates
05/08/2008WO2008052279A1 Organo-arsenoxide compounds and use thereof
05/08/2008WO2008008718B1 Cyclopentane derivatives as antiglaucoma agents
05/08/2008US20080108815 Methods for preparing and using a zinc complex
05/08/2008US20080108720 Method for manufacturing monosulfonium salt, cationic polymerization initiator, curable composition, and cured product
05/08/2008US20080108588 NO-alendronate; NO-pamidronate; NO-clodronate; NO-risedronate; NO-zolendronate; NO-etidronate; NO-ibandronate; NO-tiludronate; NO-neridronate; NO-olpadronate; NO-icadronate; NO-YH529; additional agent such as growth hormones, bone morphogenic proteins enhances bone growth or decreases bone resorption
05/08/2008US20080108545 Peptide nucleic acid linked via a disulfide bond to a triphenylphosphonium group; deliver PNA oligomers across the plasma membrane into cells; HIV infection, hepatitis C infection; melanoma, pancreatic adnocarcinoma, actue myeloid leukemia, myeloma, small cell lung cancer, prostate cancer
05/08/2008US20080108174 Methods of manufacturing a phase change memory device, in which fine contact holes can be filled stably, with little to no void formation, using metal precursor for low temperature deposition, wherein the metal is germanium, antimony, or tellurium
05/08/2008US20080107684 Immunotherapy; hypersensitivity; antiinflammatory agents; autoimmune disorders
05/08/2008US20080107628 Phosphonate inhibitors of HCV
05/08/2008US20080105866 Method of fabricating organic thin film transistor using self assembled monolayer-forming compound containing dichlorophosphoryl group
05/08/2008US20080104766 Neutral halogen-free organic phosphorus compound, modified natural oil, a neutral oil and a coemulsifier
05/08/2008DE202005021489U1 Zusammmensetzung für die Synthese von phosphitylierten Verbindungen A composition as for the synthesis of compounds phosphitylated
05/08/2008DE202005021488U1 Mischung aus einem Aktivator und einem Additiv zur Herstellung von phosphitylierten Verbindungen Mixture of an activator and an additive for preparing phosphitylated compounds
05/08/2008CA2704145A1 Butyrylcholinesterase inhibitors and their use in the treatment of neurodegenerative diseases
05/08/2008CA2668010A1 Organo-arsenoxide compounds and use thereof
05/08/2008CA2663051A1 Phosphorus-molybdenum compound, method for producing same and a lubricant additive and lubricant composition containing the compound
05/07/2008EP1918287A2 LPA receptor agonists and antagonists and methods of use
05/07/2008EP1918275A1 Production method of diphenylalanine - NI(II) complex
05/07/2008EP1917272A1 Novel coupling agent and uses thereof
05/07/2008EP1539667B1 Process for reducing fluoride impurities resulting from use of fluorophosphite catalysts
05/07/2008EP1448626B1 Process for the manufacture of polycarboxylic acids using phosphorous containing reducing agents
05/07/2008EP1404643A4 Cleavable surfactants and methods of use thereof
05/07/2008EP1296932B1 Use of compositions consisting of cationic compounds and proton donors for stabilising and/or isolating nucleic acids in or from micro-organisms such as prokaryots, fungi, protozoa or algae
05/07/2008CN101175861A Method
05/07/2008CN101172985A Improved process for producing glyphosate acid ammonium salt
05/07/2008CN101172984A Method of synthesizing general 2-methoxy phosphoric acid ester pesticide hapten
05/07/2008CN101172962A Novel intermediate for carbapenem compound for oral administration and process for producing the same
05/07/2008CN100386335C Preparation method of substituted diaryl phosphate
05/07/2008CN100386128C Process for catalyst recovery from hydrocyanation product mixtures
05/06/2008US7368604 From aroyloxyphosphines; e.g., rearrangement of trimethylbenzoyloxydiphenylphosphine to form trimethylbenzoyldiphenylphosphine oxide; optional catalysts include AlCl3, trifluoroacetic anhydride, KI, aroyl chloride and aroyl anhydride
05/06/2008US7368596 Engines with seals and lubricants in noncatalytic reactions and packages
05/06/2008US7368585 Protected trihydroxyisoalkatrienyltriphenylphosphonium halides for proparing polyhydroxylactones; acid stable protecting groups include p-methoxybenzyl and tert-butyldimethylsilyl.
05/06/2008US7368578 superior in an adipose tissue weight decreasing action and a retinoid-related receptor function regulating action; to treat obesity, diabetes mellitus, hyperlipidemia, impaired glucose tolerance, hypertension; fewer side effects; 4-{[2-(2-furyl)-1,3-oxazol-4-yl]methoxy}-3-methoxybenzaldehyde
05/06/2008US7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents
05/06/2008US7368402 Systems and methods for forming tantalum oxide layers and tantalum precursor compounds
05/06/2008CA2321923C Deeply reduced oxidation catalyst and its use for catalyzing liquid phase oxidation reactions
05/06/2008CA2274648C Polymerizable biaryls, process for their preparation and their use
05/06/2008CA2244979C Proton conductor in liquid form
05/02/2008WO2008051584A2 Process for the preparation of highly purified, dialkydithiophosphinic compounds
05/02/2008WO2008049335A1 A plant growth regulator containing hemin
05/02/2008WO2008005565A3 Antiviral phosphinate compounds
05/02/2008CA2667231A1 Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients
05/01/2008US20080103330 Single solvent extraction separation of dialkylphosphinic acid from reaction of hypophosphorous acid with alpha olefin then sulfurizing
05/01/2008US20080103321 Continuous method that minimizes or eliminates free water; reduced shipping costs; mixing phosphoric acid, acetic acid, ammonium hydroxide and alkali metal hydroxide; drying, granulating and combining with base stock hydrocarbon to form oil material
05/01/2008US20080103278 New polymer and polymer light-emitting device using the same
05/01/2008US20080103115 Phosphonate compounds
05/01/2008US20080103073 Phosphotriglycerides with optional thioguanidine group(s); epoxidizing seed oils having an unsaturated triglyceride structure; reacting with organophosphorus derivative; hydroxylation by reaction with perchloric acid; washing, purifying; extreme pressure lubricants; internal combustion engines
05/01/2008US20080103046 Process for making a plant growth regulator
04/2008
04/30/2008EP1916527A1 Analysis of mass spectral data in the quiet zones
04/30/2008EP1916251A1 Erianin salts, their preparation methods and pharmaceutical compositions containing the same
04/30/2008EP1915383A2 Bidentate catalyst for olefin polymerization, methods of forming such and products therefrom
04/30/2008EP1615936A4 Phosphates of secondary alcohols
04/30/2008DE102006050925A1 New ((4-oxo-4H-chromen-3-yl)-hydroxymethyl)- or ((4-oxo-4H-chromen-3-yl)-methyl)-phosphoric acid derivatives are elastase inhibitors useful e.g. to prepare a preparation exhibiting protecting effect against oxidative stress on body cells
04/30/2008CN101168549A 1,1'-biphenyls axial chirality diphosphinidene amide ligand connected at 5,5' position